• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于生物信息学分析鉴定与喉鳞状细胞癌发病机制和预后结局相关的核心生物标志物。

Identification of core biomarkers associated with pathogenesis and prognostic outcomes of laryngeal squamous-cell cancer using bioinformatics analysis.

机构信息

Department of Otolaryngology, Fujian Medical University Union Hospital, 29# Xinquan Road, Fujian, 350001, Fuzhou, China.

Department of Laboratory Medicine, Fujian Medical University Union Hospital, Fujian, 350001, Fuzhou, China.

出版信息

Eur Arch Otorhinolaryngol. 2020 May;277(5):1397-1408. doi: 10.1007/s00405-020-05856-5. Epub 2020 Feb 17.

DOI:10.1007/s00405-020-05856-5
PMID:32067095
Abstract

PURPOSE

Despite advances in the treatment of laryngeal squamous-cell carcinoma (LSCC), the survival rate of LSCC remains poor. Thereby, it is urgent to identify novel diagnostic and prognostic biomarkers for LSCC. The study aimed to identify potential core genes associated with the pathogenesis and prognosis of LSCC.

METHODS

Differentially expressed genes between LSCC and normal laryngeal tissue samples were screened by an integrated analysis of data from GEO and TCGA databases. Core genes related to the pathogenesis and prognosis of LSCC were identified by employing protein-protein interaction network and Cox proportional hazards model analyses.

RESULTS

Ten hub genes (AURKA, AURKB, CDC45, KIF2C, NDC80, EXO1, TYMS, RAD51AP1, ITGA3, and UBE2T) that might be highly related to the pathogenesis of LSCC were identified. An eight-gene prognostic signature consisted of ZG16B, STATH, RTN4R, MSRA, CBX8, SLC5A1, EFNB1 and CNTFR was constructed with a good performance in predicting overall survivals.

CONCLUSION

Our findings might shed some new light on the pathogenesis of LSCC and help identify new therapeutic targets of LSCC.

摘要

目的

尽管喉鳞状细胞癌(LSCC)的治疗取得了进展,但 LSCC 的生存率仍然很差。因此,迫切需要确定用于 LSCC 的新的诊断和预后生物标志物。本研究旨在确定与 LSCC 发病机制和预后相关的潜在核心基因。

方法

通过对 GEO 和 TCGA 数据库数据的综合分析,筛选 LSCC 与正常喉组织样本之间的差异表达基因。通过蛋白质-蛋白质相互作用网络和 Cox 比例风险模型分析,确定与 LSCC 发病机制和预后相关的核心基因。

结果

鉴定出 10 个可能与 LSCC 发病机制高度相关的枢纽基因(AURKA、AURKB、CDC45、KIF2C、NDC80、EXO1、TYMS、RAD51AP1、ITGA3 和 UBE2T)。构建了一个由 ZG16B、STATH、RTN4R、MSRA、CBX8、SLC5A1、EFNB1 和 CNTFR 组成的具有良好预测总生存率的 8 基因预后特征。

结论

我们的研究结果可能为 LSCC 的发病机制提供一些新的见解,并有助于确定 LSCC 的新治疗靶点。

相似文献

1
Identification of core biomarkers associated with pathogenesis and prognostic outcomes of laryngeal squamous-cell cancer using bioinformatics analysis.基于生物信息学分析鉴定与喉鳞状细胞癌发病机制和预后结局相关的核心生物标志物。
Eur Arch Otorhinolaryngol. 2020 May;277(5):1397-1408. doi: 10.1007/s00405-020-05856-5. Epub 2020 Feb 17.
2
Integrative Analysis Reveals STC2 as a Prognostic Biomarker of Laryngeal Squamous Cell Carcinoma.整合分析揭示 STC2 是喉鳞状细胞癌的预后生物标志物。
Appl Biochem Biotechnol. 2024 Jul;196(7):3891-3913. doi: 10.1007/s12010-023-04727-z. Epub 2023 Oct 4.
3
Gene expression profiling via bioinformatics analysis reveals biomarkers in laryngeal squamous cell carcinoma.通过生物信息学分析进行基因表达谱分析揭示了喉鳞状细胞癌中的生物标志物。
Mol Med Rep. 2015 Aug;12(2):2457-64. doi: 10.3892/mmr.2015.3701. Epub 2015 Apr 29.
4
Prognostic value of a microRNA-pair signature in laryngeal squamous cell carcinoma patients.miRNA 标志物对喉鳞状细胞癌患者的预后价值。
Eur Arch Otorhinolaryngol. 2022 Sep;279(9):4451-4460. doi: 10.1007/s00405-022-07404-9. Epub 2022 Apr 27.
5
The matrix metalloproteinase gene family: a significant prognostic gene lineage correlated with immune infiltrates in laryngeal squamous cell carcinoma.基质金属蛋白酶基因家族:与喉鳞状细胞癌免疫浸润相关的重要预后基因谱系。
Neoplasma. 2021 Nov;68(6):1212-1224. doi: 10.4149/neo_2021_210511N643. Epub 2021 Sep 28.
6
Aberrant expressed long non-coding RNAs in laryngeal squamous-cell carcinoma.喉鳞状细胞癌中异常表达的长非编码 RNA
Am J Otolaryngol. 2019 Sep-Oct;40(5):615-625. doi: 10.1016/j.amjoto.2019.05.002. Epub 2019 May 9.
7
Laryngeal Squamous Cell Carcinoma: Potential Molecular Mechanism and Prognostic Signature Based on Immune-Related Genes.喉鳞状细胞癌:基于免疫相关基因的潜在分子机制及预后特征
Med Sci Monit. 2020 Dec 26;26:e928185. doi: 10.12659/MSM.928185.
8
Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.对喉鳞状细胞癌中lncRNAs、mRNAs和miRNAs的差异表达谱进行综合分析,以构建ceRNA网络并鉴定潜在生物标志物。
J Cell Biochem. 2019 Oct;120(10):17963-17974. doi: 10.1002/jcb.29063. Epub 2019 May 24.
9
Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.肿瘤坏死因子超家族成员13是一种用于诊断和预后的新型生物标志物,并促进喉鳞状细胞癌中的癌细胞增殖。
Tumour Biol. 2016 Feb;37(2):2635-45. doi: 10.1007/s13277-015-4016-8. Epub 2015 Sep 23.
10
BIRC5 promotes cancer progression and predicts prognosis in laryngeal squamous cell carcinoma.BIRC5 促进喉鳞状细胞癌的进展并预测其预后。
PeerJ. 2022 Feb 1;10:e12871. doi: 10.7717/peerj.12871. eCollection 2022.

引用本文的文献

1
The m6A and immune regulatory gene signature predicts the prognosis and correlates with immune infiltration of head and neck squamous cell carcinoma.m6A与免疫调节基因特征可预测头颈部鳞状细胞癌的预后并与免疫浸润相关。
Heliyon. 2024 Oct 24;10(21):e39758. doi: 10.1016/j.heliyon.2024.e39758. eCollection 2024 Nov 15.
2
KIF2C/MCAK a prognostic biomarker and its oncogenic potential in malignant progression, and prognosis of cancer patients: a systematic review and meta-analysis as biomarker.KIF2C/MCAK 作为一种预后生物标志物及其在恶性进展和癌症患者预后中的致癌潜能的系统评价和荟萃分析。
Crit Rev Clin Lab Sci. 2024 Sep;61(6):404-434. doi: 10.1080/10408363.2024.2309933. Epub 2024 Feb 12.
3

本文引用的文献

1
SLC5A1 promotes growth and proliferation of pancreatic carcinoma via glucose-dependent AMPK/mTOR signaling.溶质载体家族5成员1(SLC5A1)通过葡萄糖依赖性的AMPK/mTOR信号通路促进胰腺癌的生长和增殖。
Cancer Manag Res. 2019 Apr 12;11:3171-3185. doi: 10.2147/CMAR.S195424. eCollection 2019.
2
Co-expression network analysis identified KIF2C in association with progression and prognosis in lung adenocarcinoma.共表达网络分析鉴定出 KIF2C 与肺腺癌的进展和预后相关。
Cancer Biomark. 2019;24(3):371-382. doi: 10.3233/CBM-181512.
3
CBX8 and CD96 Are Important Prognostic Biomarkers of Colorectal Cancer.
[Research Advances of RAD51AP1 in Tumor Progression and Drug Resistance].
[RAD51AP1在肿瘤进展和耐药性中的研究进展]
Zhongguo Fei Ai Za Zhi. 2023 Sep 20;26(9):701-708. doi: 10.3779/j.issn.1009-3419.2023.102.34.
4
Cell Cycle-Related Gene SPC24: A Novel Potential Diagnostic and Prognostic Biomarker for Laryngeal Squamous Cell Cancer.细胞周期相关基因 SPC24:喉鳞状细胞癌的一种新的潜在诊断和预后生物标志物。
Biomed Res Int. 2023 Jan 21;2023:1733100. doi: 10.1155/2023/1733100. eCollection 2023.
5
Prognostic signature related to the immune environment of oral squamous cell carcinoma.与口腔鳞状细胞癌免疫环境相关的预后标志物
Open Life Sci. 2022 Sep 14;17(1):1135-1147. doi: 10.1515/biol-2022-0467. eCollection 2022.
6
A TCR mimic CAR T cell specific for NDC80 is broadly reactive with solid tumors and hematologic malignancies.一种针对 NDC80 的 TCR 模拟 CAR T 细胞与实体瘤和血液系统恶性肿瘤广泛反应。
Blood. 2022 Aug 25;140(8):861-874. doi: 10.1182/blood.2021012882.
7
Characterization of Recurrent Relevant Genes Reveals a Novel Role of RPL36A in Radioresistant Oral Squamous Cell Carcinoma.复发性相关基因的特征揭示了RPL36A在放射性抗性口腔鳞状细胞癌中的新作用。
Cancers (Basel). 2021 Nov 10;13(22):5623. doi: 10.3390/cancers13225623.
8
Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers.三阴性乳腺癌高度异质相关基因:潜在的诊断和预后生物标志物。
BMC Cancer. 2021 May 31;21(1):644. doi: 10.1186/s12885-021-08318-1.
CBX8 和 CD96 是结直肠癌的重要预后生物标志物。
Med Sci Monit. 2018 Nov 1;24:7820-7827. doi: 10.12659/MSM.908656.
4
Identification of ITGA3 as an Oncogene in Human Tongue Cancer via Integrated Bioinformatics Analysis.通过整合生物信息学分析鉴定 ITGA3 为人舌鳞癌细胞癌基因。
Curr Med Sci. 2018 Aug;38(4):714-720. doi: 10.1007/s11596-018-1935-9. Epub 2018 Aug 20.
5
UTX is an escape from X-inactivation tumor-suppressor in B cell lymphoma.UTX 是 B 细胞淋巴瘤中 X 染色体失活肿瘤抑制因子的逃逸蛋白。
Nat Commun. 2018 Jul 13;9(1):2720. doi: 10.1038/s41467-018-05084-w.
6
Profound Tissue Specificity in Proliferation Control Underlies Cancer Drivers and Aneuploidy Patterns.深刻的组织特异性在增殖控制中是癌症驱动因素和非整倍体模式的基础。
Cell. 2018 Apr 5;173(2):499-514.e23. doi: 10.1016/j.cell.2018.02.037. Epub 2018 Mar 22.
7
Identification and validation of potential prognostic gene biomarkers for predicting survival in patients with acute myeloid leukemia.用于预测急性髓系白血病患者生存的潜在预后基因生物标志物的鉴定与验证
Onco Targets Ther. 2017 Nov 2;10:5243-5254. doi: 10.2147/OTT.S147717. eCollection 2017.
8
A seven-gene prognostic signature for rapid determination of head and neck squamous cell carcinoma survival.一个用于快速确定头颈部鳞状细胞癌生存的七基因预后标志物。
Oncol Rep. 2017 Dec;38(6):3403-3411. doi: 10.3892/or.2017.6057. Epub 2017 Oct 24.
9
SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.SLC7A11,半胱氨酸/谷氨酸转运体的一个组成部分,是喉鳞状细胞癌诊断和预后的一个新的生物标志物。
Oncol Rep. 2017 Nov;38(5):3019-3029. doi: 10.3892/or.2017.5976. Epub 2017 Sep 20.
10
Identification of miRNA-mRNA Network Associated with Acute Myeloid Leukemia Survival.鉴定与急性髓系白血病生存相关的 miRNA-mRNA 网络。
Med Sci Monit. 2017 Oct 1;23:4705-4714. doi: 10.12659/msm.903989.